Point72 Asset Management, L.P. (Steven A. Cohen) - Significant Ownership

Notable people
Steven A. Cohen
Signature - Title
/s/ Jason M. Colombo - Jason M. Colombo, Authorized Person
Location
Stamford, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Point72 Asset Management, L.P..

Significant Ownership of Point72 Asset Management, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CCCC C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $50.3M 22.6M Point72 Asset Management, L.P. Oct 17, 2025
CYBN CYBIN INC. Common Shares, no par value 9.9% $37.8M $28.3M 6.41M +299% Point72 Asset Management, L.P. Sep 30, 2025
PTNT PALATIN TECHNOLOGIES INC Common Stock, par value $0.01 per share 9.9% $23.6M 2.31M Point72 Asset Management, L.P. Nov 12, 2025
FGNX FG Nexus Inc. Common Stock, par value $0.001 per share 9.9% $23.6M $3.09M 4M +15.1% Point72 Asset Management, L.P. Sep 30, 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 9.9% $11.3M 14.3M Point72 Asset Management, L.P. Aug 22, 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $6.75M $3.38M 8M +100% Point72 Asset Management, L.P. Sep 30, 2025
IVVD Invivyd, Inc. Common Stock, par value $0.0001 per share 9.7% $22.4M $4.01M 20.4M +21.8% Point72 Asset Management, L.P. Sep 30, 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 9.6% $110M $28.7M 2.07M +35.4% Steven A. Cohen Sep 30, 2025
Aptevo Therapeutics Inc. Common Stock, par value $0.001 per share 9.1% 300K Point72 Asset Management, L.P. Sep 16, 2025
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share 8.7% $19.3M 817K Steven A. Cohen Jun 30, 2025
1RT Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share 8.7% 1.5M Point72 Asset Management, L.P. Jul 3, 2025
AVTX Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share 8% $13.4M $5.91M 1.05M +79.1% Point72 Asset Management, L.P. Sep 30, 2025
RLAY Relay Therapeutics, Inc. Common Stock, par value $0.001 per share 7.8% $47.5M $13.2M 13.4M +38.7% Point72 Asset Management, L.P. Jun 30, 2025
ANAB ANAPTYSBIO, INC Common Stock, par value $0.001 per share 7.7% $40.7M $11.6M 2.37M +40% Point72 Asset Management, L.P. Mar 31, 2025
ZEPP Zepp Health Corp Class A Ordinary Shares, par value $0.0001 per share 7.6% $402M $106M 8.78M +35.6% Point72 Asset Management, L.P. Sep 30, 2025
TENX TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 7.4% $2.04M 340K Point72 Asset Management, L.P. Oct 22, 2025
ADCT ADC Therapeutics SA Common Shares, par value CHF 0.08 per share 7% $10.5M 7.83M Point72 Asset Management, L.P. Jun 16, 2025
ANRO Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share 7% $4.06M -$963K 1.91M -19.2% Steven A. Cohen Mar 31, 2025
CLDX Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share 6.7% $84.4M 4.46M Point72 Asset Management, L.P. Jul 2, 2025
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 6.7% $6.62M 4.09M Point72 Asset Management, L.P. Aug 27, 2025
GLTO Galecto, Inc. Common Stock, par value $0.00001 per share 6.3% $380K 100K Point72 Asset Management, L.P. Nov 12, 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.2% $151M $4.8M 1.58M +3.28% Point72 Asset Management, L.P. Sep 30, 2025
WWW WOLVERINE WORLD WIDE INC /DE/ Common Stock, par value $1 per share 6.2% $139M $27.5M 5.08M +24.6% Point72 Asset Management, L.P. Sep 30, 2025
ANGO ANGIODYNAMICS INC Common Stock, par value $0.01 per share 6.2% $28.6M $4.91M 2.56M +20.7% Point72 Asset Management, L.P. Sep 30, 2025
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 6.2% $4.4M 7.59M Point72 Asset Management, L.P. Oct 6, 2025
VSTM Verastem, Inc. Common Stock, par value $0.0001 per share 6.1% $24.9M 3.34M Point72 Asset Management, L.P. Jul 25, 2025
CFLT Confluent, Inc. Class A Common Stock, par value $0.00001 per share 6% $347M $60.8M 17.5M +21.2% Point72 Asset Management, L.P. Sep 30, 2025
WOLFSPEED, INC. Common Stock, par value $0.00125 per share 6% 1.55M Steven A. Cohen Oct 9, 2025
IMNM Immunome Inc. Common Stock, par value $0.0001 per share 5.9% $34.7M 4.89M Point72 Asset Management, L.P. Jan 31, 2025
PAGS PagSeguro Digital Ltd. Class A Common Shares, par value $0.000025 per share 5.7% $101M -$23M 10.1M -18.5% Point72 Asset Management, L.P. Sep 30, 2025
MSGE Madison Square Garden Entertainment Corp. Class A Common Stock, par value $0.01 per share 5.5% $67.9M 2.24M Point72 Asset Management, L.P. Dec 31, 2024
KOD Kodiak Sciences Inc. Common Stock, par value $0.0001 per share 5.5% $28.2M 2.91M Point72 Asset Management, L.P. Aug 15, 2025
BRCB Black Rock Coffee Bar, Inc. Class A Common Stock, par value $0.00001 per share 5.4% $22.6M 948K Steven A. Cohen Nov 12, 2025
DNTH Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share 5.3% $40M $4.27M 2.12M +12% Point72 Asset Management, L.P. Sep 11, 2025
DSGN Design Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.2% $16.6M 2.94M Point72 Asset Management, L.P. Aug 27, 2025
LION Lionsgate Studios Corp. Common Shares, no par value per share 5.1% $101M 14.7M Point72 Asset Management, L.P. Oct 31, 2025
ORIC Oric Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.1% $45.2M 4.4M Point72 Asset Management, L.P. May 29, 2025
RUN Sunrun Inc. Common Stock, par value $0.0001 per share 5% $137M 11.5M Point72 Asset Management, L.P. Jun 26, 2025
IDYA IDEAYA Biosciences, Inc. Common Stock, par value $0.0001 per share 5% $80.2M 4.41M Point72 Asset Management, L.P. Jun 6, 2025
SNDX Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share 5% $66.7M $31.1M 4.33M +87.5% Point72 Asset Management, L.P. Aug 15, 2025
LENZ LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share 4.8% $63.2M 1.36M Steven A. Cohen Sep 30, 2025
REPL Replimune Group, Inc. Common Stock, par value $0.001 per share 4.7% $15.2M -$3.49M 3.63M -18.7% Point72 Asset Management, L.P. Sep 30, 2025
LLYVA Liberty Media Corp Series A Liberty Live Common Stock, par value $0.01 per share 4.6% $77.7M 1.16M Point72 Asset Management, L.P. Dec 31, 2024
VTYX Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share 4.5% $9.98M -$8.35M 3.21M -45.6% Point72 Asset Management, L.P. Sep 30, 2025
RCUS Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share 4.1% $58.9M -$20.4M 4.33M -25.7% Point72 Asset Management, L.P. Sep 30, 2025
COGT Cogent Biosciences, Inc. Common Stock, par value $0.001 per share 4% $82.6M -$60.8M 5.75M -42.4% Point72 Asset Management, L.P. Sep 30, 2025
ALTS ALT5 Sigma Corp Common Stock, par value $0.001 per share 4% 4.87M Point72 Asset Management, L.P. Aug 11, 2025
STNE StoneCo Ltd. Class A Common Shares, par value US$0.000079365 per share 3.9% $166M -$68.7M 9.97M -29.3% Point72 Asset Management, L.P. Jun 30, 2025
BCYC BICYCLE THERAPEUTICS PLC Ordinary Shares, nominal value 0.01 GBP per share 3.9% $14.3M -$14.4M 1.86M -50.2% Point72 Asset Management, L.P. Jun 30, 2025
TDOC Teladoc Health, Inc. Common Stock, par value $0.001 per share 3.3% $44.8M -$23.4M 5.8M -34.3% Point72 Asset Management, L.P. Sep 30, 2025
ATYR aTYR PHARMA INC Common Stock, par value $0.001 per share 3.2% $8.11M 2.85M Point72 Asset Management, L.P. Mar 31, 2025
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 3% $10.2M -$2.99M 2.07M -22.7% Point72 Asset Management, L.P. Sep 30, 2025
DRUG BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value 3% $4.88M 135K Point72 Asset Management, L.P. Dec 31, 2024
MBLY Mobileye Global Inc. Class A Common Stock, par value $0.01 per share 2.8% $84.8M -$3.37M 6.01M -3.82% Point72 Asset Management, L.P. Sep 30, 2025
TSEM TOWER SEMICONDUCTOR LTD Ordinary Shares, par value NIS 15.00 per share 2.6% $206M -$252M 2.85M -55% Point72 Asset Management, L.P. Sep 30, 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.6% $38.1M -$26M 2.8M -40.6% Point72 Asset Management, L.P. Sep 30, 2025
ENTX Entera Bio Ltd. Ordinary shares, par value NIS 0.0000769 per share 2.6% $2.15M -$2.76M 1.18M -56.2% Point72 Asset Management, L.P. Sep 30, 2025
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 2.5% $13M -$12.8M 4.07M -49.7% Point72 Asset Management, L.P. Sep 30, 2025
VNET VNET Group, Inc. Class A Ordinary Shares, par value $0.00001 per share 2.4% $296M -$315M 38.2M -51.6% Steven A. Cohen Jun 30, 2025
RPD Rapid7, Inc. Common Stock, par value $0.01 per share 2.4% $35M 1.5M Point72 Asset Management, L.P. Dec 31, 2024
OLMA Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.3% $4.91M 1.54M Point72 Asset Management, L.P. Mar 31, 2025
ARRY Array Technologies, Inc. Common Stock, par value $0.001 per share 2% $13M -$19.4M 3.05M -59.9% Point72 Asset Management, L.P. Mar 31, 2025
DYN Dyne Therapeutics, Inc. Common Stock, par value $0.0001 per share 1.5% $12.6M -$26.6M 1.67M -67.9% Point72 Asset Management, L.P. Mar 31, 2025
LITE Lumentum Holdings Inc. Common Stock, par value $0.001 per share 1.3% $111M -$408M 895K -78.7% Point72 Asset Management, L.P. Jun 30, 2025
SPHR Sphere Entertainment Co. Class A Common Stock, par value $0.01 per share 0.8% $13.9M -$81.5M 223K -85.4% Point72 Asset Management, L.P. Sep 30, 2025
RGLS Regulus Therapeutics Inc. Common Stock, par value $0.001 per share 0.3% $1.9M -$29M 241K -93.9% Point72 Asset Management, L.P. Jun 30, 2025
ANNX Annexon, Inc. Common Stock, par value $0.001 per share 0.1% $132K 95.4K Point72 Asset Management, L.P. Mar 31, 2025
WHWK Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $8.39K -$2.42M 5.09K -99.7% Point72 Asset Management, L.P. Mar 31, 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 0% $407 -$742K 257 -99.9% Point72 Asset Management, L.P. Sep 30, 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 0% $9.92 496 Point72 Asset Management, L.P. Dec 31, 2024
SHLS Shoals Technologies Group, Inc. Class A Common Stock, par value $0.00001 per share 0% $0 -$61.7M 0 -100% Point72 Asset Management, L.P. Jun 30, 2025
TSBX Turnstone Biologics Corp. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. Sep 30, 2025
SGMT Sagimet Biosciences Inc. Series A Common Stock, par value $0.0001 per share 0% $0 -$13.3M 0 -100% Point72 Asset Management, L.P. Jun 30, 2025
JOYY JOYY Inc. Class A Common Shares, par value US$0.00001 per share 0% $0 0 Point72 Asset Management, L.P. Mar 31, 2025
CDMO Avid Bioservices, Inc. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. Dec 31, 2024
IKT Inhibikase Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. Dec 31, 2024

Schedules 13D/G Reported by Point72 Asset Management, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.